Novavax Inc (NASDAQ:NVAX)

4.63
Delayed Data
As of 4:00pm ET
 -0.11 / -2.32%
Today’s Change
4.01
Today|||52-Week Range
51.60
-87.42%
Year-to-Date
2 Growth Stocks for In-the-Know Investors
Oct 01 / MotleyFool.com - Paid Partner Content
Are Options Traders Betting on a Big Move in Novavax (NVAX) Stock?
Sep 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close4.74
Today’s open4.78
Day’s range4.55 - 4.79
Volume425,453
Average volume (3 months)811,184
Market cap$109.1M
Data as of 4:00pm ET, 10/17/2019

Growth & Valuation

Earnings growth (last year)+20.69%
Earnings growth (this year)+45.10%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+9.98%
P/E ratioNM
Price/Sales19.84
Price/Book--

Competitors

 Today’s
change
Today’s
% change
JNCEJounce Therapeutics ...+0.01+0.29%
BTAIBioXcel Therapeutics...-0.43-6.90%
CYADCelyad SA+0.06+0.67%
APTOAptose Biosciences I...+0.04+2.07%
Data as of 4:00pm ET, 10/17/2019

Financials

Next reporting dateNovember 7, 2019
EPS forecast (this quarter)-$0.85
Annual revenue (last year)$34.3M
Annual profit (last year)-$184.7M
Net profit margin-538.81%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Gaithersburg, Maryland

Forecasts